Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia

Clinical Hemorheology and Microcirculation

Volumn 57, Issue 4, 2014, Pages 315-323

  Ercan, Meltem ^a   Firtina, Sinem ^a   Konukoglu, Dildar ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

asymmetric dimethylarginine; Atherosclerosis; nitric oxide; Oxidized LDL; plasma viscosity; shear stress

Indexed keywords

ALBUMIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; ARGININE; BIOLOGICAL MARKER; LOW DENSITY LIPOPROTEIN; N,N-DIMETHYLARGININE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CAPILLARY; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENZYME CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PLASMA VISCOSITY; TRIACYLGLYCEROL BLOOD LEVEL; VISCOMETER; AGED; ANALOGS AND DERIVATIVES; ATHEROSCLEROSIS; BLOOD; BLOOD VISCOSITY; COMPLICATION; MIDDLE AGED; PATHOLOGY; VASCULAR ENDOTHELIUM;

ADULT; AGED; ARGININE; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD VISCOSITY; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NITRIC OXIDE;

EID: 84907678995     PISSN: 13860291     EISSN: 18758622     Source Type: Journal    
DOI: 10.3233/CH-131706     Document Type: Article

References (39)

1. O.K. Baskurt, M. Boynard, G.C. Cokelet, P. Connes, B.M. Cooke, S. Forconi, F. Liao, M.R. Hardeman, F. Jung, H.J. Meiselman, G. Nash, N. Nemeth, B. Neu, B. Sandhagen, S. Shin, G. Thurston and J.L. Wautier, International Expert Panel for Standardization of Hemorheological Methods. New guidelines for hemorheological laboratory techniques, Clin Hemorheol Microcirc 42 (2009), 75-97.
2. O.K. Baskurt, H.J. Meiselman, Blood rheology and hemodynamics, Semin Thromb Hemost 29 (2003), 435-450.
3. R.H. Boger, Asymmetric dimethylarginine (ADMA) and cardiovascular disease: Insight from prospective clinical trials, Vasc Med 10 (2005), 19-25.
4. R.H. Boger, S.M. Bode-Boger, A. Szuba, P.S. Tsao, J.R. Chan, O. Tangphao, T.F. Blaschke and J.P. Cooke, . Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction - its role in hypercholesterolemia, Circulation 98 (1998), 1842-1847.
5. T. Contreras, A. Vayá, S. Palanca, E. Solá, D. Corella and J. Aznar, Influence of plasmatic lipids on the hemorheological profile in healthy adults, Clin Hemorheol Microcirc 30 (2004), 423-425.
6. J.P. Cooke, Adma: Its role in vascular disease, Vasc Med 10 (2005), 11-17.
7. J.P. Cooke, Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 20 (2000), 2032-2037.
8. K.S. Cunnigham and A.I. Gotlieb, The role of shear stress in the pathogenesis of atherosclerosis, Lab Invest 85 (2005), 9-23.
9. P.F. Davies, J.A. Spaan and R. Krams, Shear stress biology of the endothelium, Ann Biomed Eng 33 (2005), 1714-1718.
10. H.M. Eid, J. Eritsland, J. Larsen, H. Arnesen and I. Seljeflot, Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease, Effects of pravastatin, Atherosclerosis 166 (2003), 279-284.
11. M. Ercan, C. Köksal, D. Konukoglu, A.K. Bozkurt and S. Onen, Impaired plasma viscosity via increased cholesterol levels in peripheral occlusive arterial disease, Clin Hemorheol Microcirc 29 (2003), 3-9.
12. M. Ercan, D.Konukoglu, T. Erdem and S. Onen, The effects of cholesterol levels on hemorheological parameters in diabetic patients, Clin Hemorheol Microcirc 26 (2002), 257-263.
13. T. Gori, S. Dragoni, G. Di Stalfo and S. Fonconi, Endothelium and hemorheology, Ann 1st Super Sanita 43 (2007), 124-129.
14. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith Jr. and N.J. Stone, Coordinating Committee of the National Cholesterol Education Program, Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines, Circulation 110 (2004), 227-239.
15. F. Jung, G. Pindur and H. Kiesewetter, Plasma viscosity depence on proteins and lipoproteins: Results of the Aachen study, Clin Hemorheol Microcirc 12 (1992), 557-571.
16. R. Junker, J. Heinrich, H. Vibrich, H. Schulter, R. Schönfeld, E. Köhler and G. Assmann, Relationship between plasma viscosity and the severity of coronary heart disease, Arterioscler Thromb Vasc Biol 18 (1998), 870-875.
17. K.R. Kensey, Rheology, An overlooked component of vascular disease. Clin App Thrombosis & Hemostasis 9 (2003), 93-99.
18. G. Kesmarky, P. Kenreyes, M. Rabai and K. Toth, Plasma viscosity: A forgotten variable, Clin Hemorheol Microcirc 39 (2008), 243-246.
19. S.A. Kocaman, Asymmetric dimethylarginine, NO and collateral growth, Anadolu Kardiyol Derg 9 (2009), 417-420.
20. W. Koenig, M. Sund, E. Ernst, W. Mraz, V. Hombach and U. Keil, Association between rheology and components of lipoproteins in human blood, Results from the MONICA project. Circulation 85 (1992), 2197-2204.
21. W. Koenig, M. Sund, B. Filipiak, A. Döring, H. Löwel and E. Ernst, Plasma viscosity and the risk of coronary heart disease: Results from the MONICA-Augsburg Cohort Study, 1984 to 1992, Arterioscler Thromb Vasc Biol 18 (1998), 768-772.
22. G.D. Lowe, A.J. Lee, A. Rumley, J.F. Price and F.G.R. Fowkes, Blood viscosity and risk of cardiovascular events, The Edinburgh Artery Study, Br J Haematol 96 (1997), 168-173.
23. G.D. Lowe, D.A. Wood, J.T. Douglas, R.A. Riemersma, C.C. Macintyre, T. Takase, E.G. Tuddenham, C.D. Forbes, R.A. Elton and M.F. Oliver, Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina, Thromb Haemost 65 (1991), 339-343.
24. H. Miyazaki, H. Matsuoka, J.P. Cooke, M. Usui, S. Ueda, S. Okuda and T. Imaizumi, Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis, Circulation 99 (1999), 1141-1416.
25. C. Napoli, F. de Nigris, S. Williams-Ignaro, O. Pignalose, V. Sica and L.J. Ignaro, Nitric oxide and atherosclerosis, An Update, Nitric oxide 15 (2006), 265-279.
26. H. Paiva, J. Laakso, H. Laine, R. Laaksonen, J. Knuuti, O. T. Raitakari, Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia, J Am Coll Cardiol 40 (2002), 1241-1247
27. R.S. Rosenson, A. Mc Cormick and E.F. Uretz, Distribution of blood viscosity values and biochemical correlates in healthy adults, Clin Chem 42 (1996), 1189-1195.
28. K. Seki, H. Sumino, M. Nara, N. Ishiyama, M. Nishino and M. Murakami, Relationships between blood rheology and age, body mass index, blood cell count, fibrinogen, and lipids in healthy subjects, Clin Hemorheol Microcirc 34 (2006), 401-410.
29. A.M. Shaaban and A.J. Duerinckx, Wall shear stress and early atherosclerosis, A review. AJR 174 (2000), 1657-1665.
30. H. Shimokawa, Primary endothelial Dysfunction, Atherosclerosis, J Mol Cell Cardiol 31 (1999), 23-37.
31. S. Sitia, L. Tomasoni, F. Atzeni, G. Ambrosio, C. Cardiano, A. Catapono, S. Tramontana, F. Ferticone, P. Naccarato, P. Camici, E. Picano, L. Cortigiani, M. Bevilacqua, L. Milazzo, D. Cusi, C. Barlassia, P. Sarzi-Puttini and M. Turiel, From endothelial dysfunction to atherosclerosis, Autoimmunity Rev 9 (2010), 830-834.
32. D. Steinberg, Low density lipoprotein oxidation and its pathophysiological significance, J Biol Chem 272 (1997), 20963-20966.
33. A. Surdacki, M. Nowicki, J. Sandmann, D. Tsikas, R.H. Boeger, S.M. Bode-Boeger, O. Kruszelnicka-Kwiatkowska, F. Kokot, J.S. Dubiel and J.C. Froelich, Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension, J Cardiovasc Pharmacol 33 (1999), 652-658.
34. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report, " Circulation 106 (2002), 3143-3421.
35. Y. Tomiyama, J.E. Brian and M.M. Todd, Plasma viscosity and cerebral blood flow, Am J Physiol Heart Circ Physiol 279 (2000), 949-954.
36. P. Vallance and J. Leiper, Cardiovascular biology of the asymmetric dimethylarginine, Dimethylarginine Dimethylaminohyrase pathway, Arterioscler Thromb Vasc Biol 24 (2004), 1023-1030.
37. I. Velcheva, N. Antonova, E. Titianova, P. Damianov, N. Dimitrov and V. Dimitrova, Hemorheological disturbances in cerebrovascular disease, Clin Hemorheol Microcirc 39 (2008), 391-396.
38. L. Vladimirova-Kitova, T. Deneva, E. Angelova, F. Nikolov, B. Marinov and N. Mateva, Relationship of asymmetric dimethylarginine with flow-mediated dilatation in subjects with newly detected severe hypercholesterolemia, Clin Physiol Funct Imaging 28 (2008), 417-425.
39. W.Z. Zhang, K.Venardos, S. Finch and D.M. Kaye, Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation, Int J Biochem Cell Biol 40 (2008), 920-928.